RxDoctor Payments Data

Jason Reel, DPM

Podiatrist · Lufkin, TXNPI 1588607360

Payments from drug & device makers

What this record shows

This record is dominated by other: $91,360 of the $95,402 with a category attached, or 95.8%. 9 manufacturers reported payments, led by Triad Life Sciences Inc. at 48.4% of the total. Reporting peaked in 2022 at $47,316 and has fallen 99.9% since, to $43 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,402in general payments, 2019–2025

Across 103 payments — averaging $926.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Triad Life Sciences Inc.$46K
  • Convatec Inc.$45K
  • Treace Medical Concepts, Inc.$2K
  • Pylant Medical$1K
  • Organogenesis Inc.$1K
  • Medtronic$72
  • plus $85 from 3 others

What the payments were for

  • Speaking & faculty fees$120%
  • Travel & lodging$1,2581%
  • Food & beverage$1,6582%
  • Education$1,1151%
  • Other$91,36096%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$95,402 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.

See all podiatrist providers in Texas

Medicare billing

Part B allowed, 2024
$393,924
Medicare patients
349
Services billed
2,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen143$3,291
Celecoxib23$1,962
Ciclopirox59$1,591
Gabapentin41$826
Clindamycin Hcl43$753
Pregabalin28$630
Terbinafine Hcl30$590
Mupirocin60$547
Diclofenac Sodium31$497
Acetaminophen-CodeineAcetaminophen With Codeine36$378
Pentoxifylline12$376
Doxycycline Hyclate32$330
Ketoconazole23$289
Methylprednisolone30$284
Doxycycline Monohydrate20$272

Paid to pharmacies, not to this prescriber.

Other podiatrist in Lufkin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →